Trials / Completed
CompletedNCT04192630
A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50
A Study to Document the Safety and Effectiveness of a New Cohesive OVD When Compared to a Control OVD
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 390 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to evaluate the safety and effectiveness of the Bausch \& Lomb CVisc50 cohesive OVD compared to the Alcon ProVisc® cohesive OVD when used in cataract surgery.
Detailed description
The objective of the study is to evaluate the safety and effectiveness of the Bausch \& Lomb CVisc50 cohesive OVD compared to the Alcon ProVisc® cohesive OVD when used in cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CVisc50 OVD | Bausch + Lomb CVisc50 Cohesive OVD |
| DEVICE | ProVisc OVD | ProVisc OVD |
| PROCEDURE | Cataract Surgery | Cataract Surgery |
Timeline
- Start date
- 2019-11-26
- Primary completion
- 2022-01-31
- Completion
- 2022-01-31
- First posted
- 2019-12-10
- Last updated
- 2024-05-28
- Results posted
- 2024-05-28
Locations
22 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04192630. Inclusion in this directory is not an endorsement.